By GREGORY ZELLER //
A rapidly growing drug-maker may be able to keep up with skyrocketing “business dynamics” on Long Island, with a little help from the Brookhaven Industrial Development Agency.
The IDA on Wednesday announced that it has accepted an application for a tax-relief package from Amneal Pharmaceuticals LLC, designed to help the New Jersey-based generic-pharma manufacturer expand its Island operations.
Amneal Pharmaceuticals, which weighs in as the fifth-largest U.S. generics manufacturer, already operates a 410,000-square-foot facility in Yaphank, in addition to operations in Hauppauge and Commack. Now, the Brookhaven IDA is considering an application that would help the manufacturer lease an additional 84,000 square feet of space on Nichols Drive in Yaphank “to accommodate its growing space needs,” according to the IDA.
The roughly 84,000 square feet at 19 Nichols Drive is now largely storage space, the IDA said in a statement, and Amneal Pharmaceuticals is looking to convert it into space for both manufacturing and research and development. The $1.1 million renovation plan is projected to create seven new jobs, according to the IDA.
If it moves ahead with the plan, the company will relocate operations to Yaphank from its current Commack location, which is scheduled to close. It will also bring to town “some manufacturing” currently taking place at a California plant, the IDA said.
The economic-incentives application, which had its first public airing at the IDA’s Sept. 10 meeting, is subject to a full development-agency review and another public hearing before it can be approved.
But Brookhaven IDA Chairman Frederick Braun III suggested something of a done deal, noting Wednesday that “Amneal’s continued expansion in our town proves that Brookhaven is a great place to grow your business and be successful.”
“They have really embraced Brookhaven,” the chairman added.
And Amneal Pharmaceuticals might not be done expanding in Yaphank. The structure at 19 Nichols Drive, owned by Plainview-based Rechler Equity Partners, measures more than 232,000 square feet in total, and IDA officials “anticipate” that Amneal will fill additional space at the same address in the future.
Amneal Pharmaceuticals Senior Vice President Miguel Gomez said growing operations inside the Nichols Drive building, which stretches out over the equivalent of five football fields, makes sense for the manufacturer, which boasts significant operations in New Jersey and Kentucky and an international headquarters in Switzerland, and needs additional Brookhaven space “due to business dynamics.”
“The fastest way to accommodate the process was to build additional manufacturing rooms into the existing warehouse,” Gomez said in a statement.